Autopsy report · NCT03515330

A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients

“Merged IRB study created”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Medication Adherence; Liver Transplant

Interventions

mHealth Intervention

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
  “IRB Study Closure” (75% match in meaning)
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
  “Study did not receive IRB approval, so did not start” (72% match in meaning)
• Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
  “did not move forward with IRB approval, competing study” (72% match in meaning)
• Methadone as an Alternative Treatment for Children Underdoing HSCT
  “Study is closed with the IRB due to no funding. May resume once funding is obtained.” (72% match in meaning)
• The Effect of Movement Education on Jumping/Landing Quality in High School Athletes
  “Study was updated and is now under IRB #2023-0499” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.